Lynette Sholl
Associate Professor of Pathology, Harvard Medical School · Mass General Brigham
Credentials: · · · ·
History
- Present
PresentHarvard School of Public Health · University of Michigan
- 2008–2009
Molecular Genetic Pathology
Research
STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma
Cancer Discovery · 2018 · 1,415 citations
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
Journal of Thoracic Oncology · 2022 · 1,328 citations
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
Review · Nature Reviews Clinical Oncology · 2021 · 1,282 citations
62 papers
- MA
60 papers
- NL
42 papers
41 papers · 31 as a resident
32 papers
- BJ
30 papers
- MM
30 papers
30 papers
Grants
- 2022–2027
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
National Cancer Institute · P50
Project lead · $380.1K · Dana-Farber Cancer Inst